MP689EFFICACY AND SAFETY OF LOW DOSE VERSUS HIGH DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN INTERMEDIATE RISK KIDNEY TRANSPLANT RECIPIENTS

Autor:	Torki Al-Otaibi, Hassaneen Abu-Atteya, Yahia Makkeya, Zakaria Zakaria, Medhat Abdel Halim, Prasad Nair, Ahmed Mosaad, Hany Adel, M.R.N. Nampoory, Tarek Said, Osama Gheith
Rok vydání:	2016
Předmět:	Transplantation medicine.medical_specialty business.industry Low dose Valganciclovir Kidney transplant Gastroenterology Nephrology Internal medicine medicine Cytomegalovirus disease business Intermediate risk medicine.drug
Zdroj:	Nephrology Dialysis Transplantation. 31:i568-i569
ISSN:	1460-2385 0931-0509
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4c781f7d281ca87b4f77ac16d8139d82 https://doi.org/10.1093/ndt/gfw200.13 Zobrazit plný text záznamu